Profile
Amato J.
Giaccia is the founder of Proacta, Inc. (founded in 2001), Arresto BioSciences, Inc. (founded in 2007), and Aravive Biologics, Inc. (founded in 2010).
He held the title of Director & Chief Scientific Officer at Aravive Biologics, Inc. from 2017 to 2018.
Dr. Giaccia is also the founder of AKSO Biopharmaceutical, Inc. Dr. Giaccia's current job(s) include being the Associate Director-Basic Science at Stanford Cancer Institute and a Professor at Stanford University School of Medicine.
Dr. Giaccia's former job(s) include being the Director at Oxford Institute for Energy Studies and Versartis, Inc. He also served as an Independent Director at Aravive, Inc. from 2018 to 2024.
Dr. Giaccia obtained a doctorate degree from the University of Pennsylvania.
Dr. Giaccia is also the founder of AKSO Biopharmaceutical, Inc...
Amato Giaccia active positions
| Companies | Position | Start |
|---|---|---|
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines to treat cancer and fibrotic diseases | Founder | 14/08/2009 |
Stanford Cancer Institute
Stanford Cancer Institute Miscellaneous Commercial ServicesCommercial Services Operates as an NCI-designated center for translating cancer research into improved patient outcomes | Corporate Officer/Principal | - |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
AKSO Biopharmaceutical, Inc. | Founder | - |
Former positions of Amato Giaccia
| Companies | Position | End |
|---|---|---|
| ARAVIVE, INC. | Director/Board Member | 17/01/2024 |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Deals with development of biopharmaceutical industry | Founder | 12/10/2018 |
Oxford Institute for Energy Studies
Oxford Institute for Energy Studies Miscellaneous Commercial ServicesCommercial Services Operates as an energy research institute | Director/Board Member | - |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Director/Board Member | - |
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Develops drugs to treat cancer | Founder | - |
Training of Amato Giaccia
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Develops drugs to treat cancer | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Institute for Energy Studies
Oxford Institute for Energy Studies Miscellaneous Commercial ServicesCommercial Services Operates as an energy research institute | Commercial Services |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines to treat cancer and fibrotic diseases | Commercial Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Stanford Cancer Institute
Stanford Cancer Institute Miscellaneous Commercial ServicesCommercial Services Operates as an NCI-designated center for translating cancer research into improved patient outcomes | Commercial Services |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Deals with development of biopharmaceutical industry | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
AKSO Biopharmaceutical, Inc. |
- Stock Market
- Insiders
- Amato Giaccia
















